Abstract:Many transcription factors play a key role in cellular differentiation and the delineation of cell phenotype. Transcription factors are regulated by phosphorylation, ubiquitination, acetylation/deacetylation and interactions between two or more proteins controlling multiple signaling pathways. These pathways regulate different physiological processes and pathological events, such as cancer and other diseases. The Forkhead box O (FOXO) is one subfamily of the fork head transcription factor family with important roles in cell fate decisions and this subfamily is also suggested to play a pivotal functional role as a tumor suppressor in a wide range of cancers. During apoptosis, FOXOs are involved in mitochondria-dependent and -independent processes triggering the expression of death receptor ligands like Fas ligand, TNF apoptosis ligand and Bcl‑XL, bNIP3, Bim from Bcl-2 family members. Different types of growth factors like insulin play a vital role in the regulation of FOXOs. The most important pathway interacting with FOXO in different types of cancers is the PI3K/AKT pathway. Some other important pathways such as the Ras-MEK-ERK, IKK and AMPK pathways are also associated with FOXOs in tumorigenesis. Therapeutically targeting the FOXO signaling pathway(s) could lead to the discovery and development of efficacious agents against some cancers, but this requires an enhanced understanding and knowledge of FOXO transcription factors and their regulation and functioning. This review focused on the current understanding of cell biology of FOXO transcription factors which relates to their potential role as targets for the treatment and prevention of human cancers. We also discuss drugs which are currently being used for cancer treatment along with their target pathways and also point out some potential drawbacks of those drugs, which further signifies the need for development of new drug strategies in the field of cancer treatment.

Role of the Forkhead Transcription Factor FOXO-FOXM1 Axis in Cancer and Drug Resistance

Role And Regulation Of The Forkhead Transcription Factors Foxo3a And Foxm1 In Carcinogenesis And Drug Resistance

The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance

FOXO and FOXM1 in Cancer: the FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy.

FOXN Transcription Factors: Regulation and Significant Role in Cancer

FOXN Transcription Factors: Regulation and Significant Role in Cancer.

Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance.

Research Progress in the Relationship Between FOXM1 and Neoplasm Metabolism

Research Progress on the Regulatory Mechanisms of FOXC1 Expression in Cancers and Its Role in Drug Resistance.

Role and regulation of FOXO3a: new insights into breast cancer therapy

FOXM1: From cancer initiation to progression and treatment.

FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer

The emerging roles of forkhead box (Fox) proteins in cancer

Research Progress on the Role of FOXOs Family in Cancer

FOXO Signaling Pathways as Therapeutic Targets in Cancer

Resist or Die: FOXO Transcription Factors Determine the Cellular Response to Chemotherapy.

Mechanisms Controlling the Anti-Neoplastic Functions of FoxO Proteins.

Retraction Note To: FoxM1 Down-Regulation Leads to Inhibition of Proliferation, Migration and Invasion of Breast Cancer Cells Through the Modulation of Extra-Cellular Matrix Degrading Factors

Novel Role of Forkhead Box O 4 Transcription Factor in Cancer: Bringing out the Good or the Bad

FOXA1 is a determinant of drug resistance in breast cancer cells

Role of Forkhead Box Class O proteins in cancer progression and metastasis